CLINICAL RELEVANCE: DRUG–DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS, AND TOXICITY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 866

758. Sawada K, Terada T, Saito H, Hashimoto Y, Inui K. 1999. Effects of glibenclamide
on glycylsarcosine transport by the rat peptide transporters PEPT1 and PEPT2. Br J
Pharmacol 128: 1159-1164.
759. Terada T, Sawada K, Saito H, Hashimoto Y, Inui K. 2000. Inhibitory effect of novel oral
hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2.
Eur J Pharmacol 392: 11-17.
760. Knutter I, Theis S, Hartrodt B, Born I, Brandsch M, Daniel H, Neubert K. 2001. A novel
inhibitor of the mammalian peptide transporter PEPT1. Biochemistry 40: 4454-4458.
761. Theis S, Knutter I, Hartrodt B, Brandsch M, Kottra G, Neubert K, Daniel H. 2002.
Synthesis and characterization of high affinity inhibitors of the H + /peptide transporter
PEPT2. J Biol Chem 277: 7287-7292.
762. Akarawut W, Lin CJ, Smith DE. 1998. Noncompetitive inhibition of glycylsarcosine
transport by quinapril in rabbit renal brush border membrane vesicles: effect on
high-affinity peptide transporter. J Pharmacol Exp Ther 287: 684-690.
763. Lin CJ, Akarawut W, Smith DE. 1999. Competitive inhibition of glycylsarcosine
transport by enalapril in rabbit renal brush border membrane vesicles: interaction
of ACE inhibitors with high-affinity H + /peptide symporter. Pharm Res 16: 609-
615.
764. Swaan PW, Stehouwer MFC, Tukker JJ. 1995. Molecular mechanism for the relative
binding affinity to the intestinal peptide carrier. Comparison of three ACE inhibitors:
enalapril, enalaprilat, and lisinopril. Biochim Biophys Acta 1236: 31-38.
765. Thamotharan M, Bawani SZ, Zhou X, Adibi SA. 1999. Hormonal regulation of
oligopeptide transporter PepT-1 in a human intestinal cell line. Am J Physiol Cell Physiol
276: C821-C826.
766. Sun BW, Zhao XC, Wang GJ, Li N, Li JS. 2003. Hormonal regulation of dipeptide
transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.
World J Gastroenterol 9: 808-812.
767. Berlioz F, Maoret JJ, Paris H, Laburthe M, Farinotti R, Roze C. 2000. 2-Adrenergic
receptors stimulate oligopeptide transport in a human intestinal cell line. J Pharmacol
Exp Ther 294: 466-472.
768. Buyse M, Berlioz F, Guilmeau S, Tsocas A, Voisin T, Peranzi G, Merlin D, Laburthe
M, Lewin MJ, Roze C, Bado A. 2001. PepT1 mediates epithelial transport of dipeptides
and cephalexin is enhanced by luminal leptin in the small intestine. J Clin Invest 108:
1483-1494.
769. Fujita T, Majikawa Y, Umehisa S, Okada N, Yamamoto A, Ganapathy V, Leibach FH.
1999. Sigma receptor ligand-induced up-regulation of the H + /peptide transporter PEPT1
in the human intestinal cell line Caco-2. Biochem Biophys Res Commun 261: 242-246.
770. Wenzel U, Kuntz S, Diestel S, Daniel H. 2002. PEPT1-mediated cefixime uptake into
human intestinal epithelial cells is increased by Ca2 + channel blockers. Antimicrob
Agents Chemother 46: 1375-1380.
771. Ashida K, Katsura T, Motohashi H, Saito H, Inui K. 2002. Thyroid hormone regulates
the activity and expression of the peptide transporter PepT1 in Caco-2 cells. Am J
Physiol Gastrointest Liver Physiol 282: G617-G623.
772. Nielsen CU, Amstrup J, Steffansen B, Frokjaer S, Brodin B. 2001. Epidermal growth
factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal
cell line. Am J Physiol Gastrointest Liver Physiol 281: G191-G199.